Clinical Trials at Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
As of June 2026, 115 paid clinical trials are recruiting at Memorial Sloan Kettering Monmouth (Limited Protocol Activities), located at 480 RED HILL RD, MIDDLETOWN, NJ 07748-3052, phone (212) 639-2000 in Middletown, New Jersey. Active studies at this site cover conditions such as Breast Cancer, Multiple Myeloma and Acute Myeloid Leukemia. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
115 clinical trials at Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
·Clear filters·↓ Download CSVA Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
A Study of Mirdametinib in People With Central Nervous System Tumors
A Study of Ivonescimab in People With Leiomyosarcoma
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
A Dietary Study for People With Multiple Myeloma
A Study of 177Lu-PSMA-617 in People With Gliomas
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
A Study of Surgery and Radiotherapy in People With Breast Cancer
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
A Study of Tarlatamab for People With Prostate Cancer
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
A Study of Changes to Prostate Procedures
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
A Study of Hospital-at-Home for People Receiving Tarlatamab
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)
A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
A Study of Sotorasib in People With Brain Tumors
About research studies in Middletown
Middletown has approximately 312 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in Middletown
- Breast Cancer (28 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Multiple Myeloma (13 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (11 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Metastatic Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Non-Small Cell Lung Cancer (10 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Prostate Cancer (9 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
Leading research sponsors in Middletown
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Pfizer
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Middletown. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Middletown
Hipa.ai aggregates every recruiting study in Middletown from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Middletown?
There are approximately 312 recruiting clinical trials in Middletown, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Middletown pay participants?
Most recruiting trials in Middletown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Middletown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Middletown?
The most common conditions under active study in Middletown include Breast Cancer (28), Multiple Myeloma (13), Acute Myeloid Leukemia (11), Metastatic Breast Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Middletown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Middletown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Middletown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Middletown?
Recruiting research sites in Middletown include Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Memorial Sloan Kettering Monmouth, Memorial Sloan Kettering Monmouth (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Middletown right now?
The largest active categories in Middletown are Cancer & tumors (252), Neurology & pain (3), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Monmouth (Limited Protocol Activities)?
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) is located at 480 RED HILL RD, MIDDLETOWN, NJ 07748-3052. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Monmouth (Limited Protocol Activities)?
You can reach Memorial Sloan Kettering Monmouth (Limited Protocol Activities) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.